BioWorld looks at translational medicine, including: Engineered opsin restores vision.

A multi-institutional team of researchers has implicated lipid droplets, which are key energy storage units of individual cells, in innate immune defense.

Investigators at the ECOG-ACRIN Cancer Research Group and the National Cancer Institute reported a roughly 40% match rate of patients to molecularly targeted therapies in its NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) trial, ultimately leading to molecularly targeted treatments for almost 20% of trial participants.

BioWorld looks at translational medicine, including: PDAC subtypes point to targeting strategies; Lactose tolerance may be Red Herring.

“It’s coming. We know it’s coming.” That was Nevan Krogan’s blunt reminder that SARS-CoV-2 is not the first virus to wreak temporary havoc on humanity, nor will it be the last.

BioWorld looks at translational medicine, including: SWI/SNF mutations can lead to gain of function.

Two teams of researchers have developed miniature models of the human heart that beat and function like the full-size organ.

BioWorld looks at translational medicine, including: Neutrophils are literal obstacle to stroke recovery.

Investigators at the University of Heidelberg have identified a previously unknown mechanism for excitotoxicity and used their insight to identify “unconventional neuroprotectant” compounds that could prevent cell death and reduce brain damage in a mouse model of stroke.

BioWorld looks at translational medicine, including: Fat-free mice have bigger bones.